Format

Send to:

Choose Destination
See comment in PubMed Commons below
Respiration. 2008;75(2):211-4. Epub 2005 Nov 15.

Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan.

Author information

  • 1Division of Pulmonary/Critical Care Medicine, University of Connecticut School of Medicine, Farmington, Conn., USA. rfoley@uchc.edu

Abstract

Sarcoidosis is a systemic granulomatous disease of unknown etiology, in which the lungs and intrathoracic lymph nodes are predominant sites of involvement. Pulmonary hypertension is a known complication of sarcoidosis. Treatment of sarcoidosis-associated pulmonary hypertension has traditionally focused on the initiation of systemic corticosteroids, but has had inconsistent results. We present a patient with sarcoidosis-associated pulmonary hypertension who achieved substantial clinical improvement with the dual endothelin receptor antagonist bosentan.

Copyright (c) 2008 S. Karger AG, Basel

PMID:
16293957
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk